Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
13420 | 838 | 35.6 | 59% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
375 | 3 | MELANOMA//DERMATOLOGY//DERMATOL | 32727 |
243 | 2 | MELANOMA//MALIGNANT MELANOMA//DERMOSCOPY | 19979 |
13420 | 1 | NG2 PROTEOGLYCAN//PERICYTE ENDOTHELIAL CELL INTERACTION//POLYVALENT ANTIGEN | 838 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | NG2 PROTEOGLYCAN | authKW | 248417 | 2% | 45% | 15 |
2 | PERICYTE ENDOTHELIAL CELL INTERACTION | authKW | 109311 | 0% | 100% | 3 |
3 | POLYVALENT ANTIGEN | authKW | 101209 | 1% | 56% | 5 |
4 | CSPG4 | authKW | 87441 | 1% | 40% | 6 |
5 | CANC CANC PATHOL | address | 72874 | 0% | 100% | 2 |
6 | CANC CANC UROL | address | 72874 | 0% | 100% | 2 |
7 | HIGH MOLECULAR WEIGHT MELANOMA ASSOCIATED ANTIGEN HMW MAA | authKW | 72874 | 0% | 100% | 2 |
8 | MELANOMA CHONDROITIN SULFATE PROTEOGLYCAN | authKW | 72874 | 0% | 100% | 2 |
9 | COMT MOL TRANSLAT ONCOL | address | 72870 | 0% | 50% | 4 |
10 | AUTOLOGOUS ANTIBODY | authKW | 65584 | 0% | 60% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 7083 | 48% | 0% | 399 |
2 | Immunology | 1579 | 22% | 0% | 184 |
3 | Dermatology | 583 | 7% | 0% | 57 |
4 | Pathology | 416 | 7% | 0% | 58 |
5 | Cell Biology | 139 | 9% | 0% | 72 |
6 | Biochemical Research Methods | 118 | 5% | 0% | 41 |
7 | Medicine, Research & Experimental | 77 | 5% | 0% | 40 |
8 | Biology | 48 | 3% | 0% | 24 |
9 | Medical Laboratory Technology | 26 | 1% | 0% | 10 |
10 | Biotechnology & Applied Microbiology | 24 | 4% | 0% | 32 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANC CANC PATHOL | 72874 | 0% | 100% | 2 |
2 | CANC CANC UROL | 72874 | 0% | 100% | 2 |
3 | COMT MOL TRANSLAT ONCOL | 72870 | 0% | 50% | 4 |
4 | BIOL BUSINESS DEV | 36437 | 0% | 100% | 1 |
5 | BIOL SCI MICROBIOL 484 W 12TH AVE | 36437 | 0% | 100% | 1 |
6 | BIOMOL CHEM IMM NCLMS | 36437 | 0% | 100% | 1 |
7 | BRAIN TUMOR NEUROSCI BEHAV MED | 36437 | 0% | 100% | 1 |
8 | CELLULAR NEUROPHYSIOL GRPCELLULAR MOL MED | 36437 | 0% | 100% | 1 |
9 | DERMATOL 550 1ST AVE | 36437 | 0% | 100% | 1 |
10 | EVALUAT SCI PROGRAMS | 36437 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | METHODS IN CANCER RESEARCH | 17255 | 0% | 16% | 3 |
2 | HYBRIDOMA | 12614 | 3% | 1% | 27 |
3 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 11450 | 4% | 1% | 37 |
4 | BIOMEMBRANES | 9106 | 0% | 13% | 2 |
5 | CANCER RESEARCH | 7016 | 10% | 0% | 87 |
6 | INTERNATIONAL JOURNAL OF CANCER | 4115 | 6% | 0% | 48 |
7 | EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 3771 | 2% | 1% | 14 |
8 | JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2302 | 3% | 0% | 26 |
9 | PIGMENT CELL RESEARCH | 2157 | 1% | 1% | 8 |
10 | ANTICANCER RESEARCH | 1911 | 4% | 0% | 32 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NG2 PROTEOGLYCAN | 248417 | 2% | 45% | 15 | Search NG2+PROTEOGLYCAN | Search NG2+PROTEOGLYCAN |
2 | PERICYTE ENDOTHELIAL CELL INTERACTION | 109311 | 0% | 100% | 3 | Search PERICYTE+ENDOTHELIAL+CELL+INTERACTION | Search PERICYTE+ENDOTHELIAL+CELL+INTERACTION |
3 | POLYVALENT ANTIGEN | 101209 | 1% | 56% | 5 | Search POLYVALENT+ANTIGEN | Search POLYVALENT+ANTIGEN |
4 | CSPG4 | 87441 | 1% | 40% | 6 | Search CSPG4 | Search CSPG4 |
5 | HIGH MOLECULAR WEIGHT MELANOMA ASSOCIATED ANTIGEN HMW MAA | 72874 | 0% | 100% | 2 | Search HIGH+MOLECULAR+WEIGHT+MELANOMA+ASSOCIATED+ANTIGEN+HMW+MAA | Search HIGH+MOLECULAR+WEIGHT+MELANOMA+ASSOCIATED+ANTIGEN+HMW+MAA |
6 | MELANOMA CHONDROITIN SULFATE PROTEOGLYCAN | 72874 | 0% | 100% | 2 | Search MELANOMA+CHONDROITIN+SULFATE+PROTEOGLYCAN | Search MELANOMA+CHONDROITIN+SULFATE+PROTEOGLYCAN |
7 | AUTOLOGOUS ANTIBODY | 65584 | 0% | 60% | 3 | Search AUTOLOGOUS+ANTIBODY | Search AUTOLOGOUS+ANTIBODY |
8 | HMW MAA | 58294 | 0% | 40% | 4 | Search HMW+MAA | Search HMW+MAA |
9 | NG2 | 52099 | 2% | 8% | 17 | Search NG2 | Search NG2 |
10 | B700 | 48581 | 0% | 67% | 2 | Search B700 | Search B700 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | NICOLOSI, PA , DALLATOMASINA, A , PERRIS, R , (2015) THERANOSTIC IMPACT OF NG2/CSPG4 PROTEOGLYCAN IN CANCER.THERANOSTICS. VOL. 5. ISSUE 5. P. 530 -544 | 69 | 46% | 2 |
2 | CAMPOLI, M , FERRONE, S , WANG, XH , (2010) FUNCTIONAL AND CLINICAL RELEVANCE OF CHONDROITIN SULFATE PROTEOGLYCAN 4.ADVANCES IN CANCER RESEARCH, VOL 109. VOL. 109. ISSUE . P. 73 -121 | 56 | 35% | 27 |
3 | CATTARUZZA, S , NICOLOSI, PA , BRAGHETTA, P , PAZZAGLIA, L , BENASSI, MS , PICCI, P , LACRIMA, K , ZANOCCO, D , RIZZO, E , STALLCUP, WB , ET AL (2013) NG2/CSPG4COLLAGEN TYPE VI INTERPLAYS PUTATIVELY INVOLVED IN THE MICROENVIRONMENTAL CONTROL OF TUMOUR ENGRAFTMENT AND LOCAL EXPANSION.JOURNAL OF MOLECULAR CELL BIOLOGY. VOL. 5. ISSUE 3. P. 176-193 | 28 | 56% | 11 |
4 | CAMPOLI, MR , CHANG, CC , KAGESHITA, T , WANG, X , MCCARTHY, JB , FERRONE, S , (2004) HUMAN HIGH MOLECULAR WEIGHT-MELANOMA-ASSOCIATED ANTIGEN (HMW-MAA): A MELANOMA CELL SURFACE CHONDROITIN SULFATE PROTEOGLYCAN (MSCP) WITH BIOLOGICAL AND CLINICAL SIGNIFICANCE.CRITICAL REVIEWS IN IMMUNOLOGY. VOL. 24. ISSUE 4. P. 267-296 | 49 | 38% | 81 |
5 | GERSTEN, DM , HEARING, VJ , (1992) ANTIGENS OF MURINE MELANOMA AND THEIR CROSS-SPECIES REACTIVITY.PATHOBIOLOGY. VOL. 60. ISSUE 1. P. 49-56 | 43 | 72% | 2 |
6 | JAMIL, NSM , AZFER, A , WORRELL, H , SALTER, DM , (2016) FUNCTIONAL ROLES OF CSPG4/NG2 IN CHONDROSARCOMA.INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY. VOL. 97. ISSUE 2. P. 178 -186 | 23 | 56% | 0 |
7 | PRICE, MA , WANSHURA, LEC , YANG, JB , CARLSON, J , XIANG, B , LI, GY , FERRONE, S , DUDEK, AZ , TURLEY, EA , MCCARTHY, JB , (2011) CSPG4, A POTENTIAL THERAPEUTIC TARGET, FACILITATES MALIGNANT PROGRESSION OF MELANOMA.PIGMENT CELL & MELANOMA RESEARCH. VOL. 24. ISSUE 6. P. 1148-1157 | 29 | 44% | 28 |
8 | HERLYN, M , KOPROWSKI, H , (1988) MELANOMA ANTIGENS - IMMUNOLOGICAL AND BIOLOGICAL CHARACTERIZATION AND CLINICAL-SIGNIFICANCE.ANNUAL REVIEW OF IMMUNOLOGY. VOL. 6. ISSUE . P. 283-308 | 57 | 47% | 93 |
9 | YADAVILLI, S , HWANG, EI , PACKER, RJ , NAZARIAN, J , (2016) THE ROLE OF NG2 PROTEOGLYCAN IN GLIOMA.TRANSLATIONAL ONCOLOGY. VOL. 9. ISSUE 1. P. 57 -63 | 28 | 43% | 0 |
10 | HERLYN, M , CLARK, WH , RODECK, U , MANCIANTI, ML , JAMBROSIC, J , KOPROWSKI, H , (1987) BIOLOGY OF TUMOR PROGRESSION IN HUMAN MELANOCYTES.LABORATORY INVESTIGATION. VOL. 56. ISSUE 5. P. 461-474 | 48 | 42% | 216 |
Classes with closest relation at Level 1 |